{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:46:22Z","timestamp":1792320382397,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10633-015-9518-6","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T22:21:13Z","timestamp":1446502873000},"page":"237-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Linezolid induced retinopathy"],"prefix":"10.1007","volume":"131","author":[{"given":"Dae Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Kwann","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Ohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Ho","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"9518_CR1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00003495-200161040-00008","volume":"61","author":"CM Perry","year":"2001","unstructured":"Perry CM, Jarvis B (2001) Linezolid: a review of its use in the management of serious gram-positive infections. Drugs 61:525\u2013551","journal-title":"Drugs"},{"key":"9518_CR2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1183\/09031936.00022912","volume":"40","author":"G Sotgiu","year":"2012","unstructured":"Sotgiu G, Centis R, D\u2019Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB (2012) Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 40:1430\u20131442","journal-title":"Eur Respir J"},{"key":"9518_CR3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s15010-014-0632-2","volume":"42","author":"L Zhang","year":"2014","unstructured":"Zhang L, Pang Y, Yu X, Wang Y, Gao M, Huang H, Zhao Y (2014) Linezolid in the treatment of extensively drug-resistant tuberculosis. Infection 42:705\u2013711","journal-title":"Infection"},{"key":"9518_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1183\/09031936.00145014","volume":"45","author":"G Sotgiu","year":"2015","unstructured":"Sotgiu G, Pontali E, Migliori GB (2015) Linezolid to treat MDR-\/XDR-tuberculosis: available evidence and future scenarios. Eur Respir J 45:25\u201329","journal-title":"Eur Respir J"},{"key":"9518_CR5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/00498250210158249","volume":"32","author":"JG Slatter","year":"2002","unstructured":"Slatter JG, Adams LA, Bush EC, Chiba K, Daley-Yates PT, Feenstra KL, Koike S, Ozawa N, Peng GW, Sams JP, Schuette MR, Yamazaki S (2002) Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica 32:907\u2013924","journal-title":"Xenobiotica"},{"key":"9518_CR6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0149-2918(01)80043-6","volume":"23","author":"HB Fung","year":"2001","unstructured":"Fung HB, Kirschenbaum HL, Ojofeitimi BO (2001) Linezolid: an oxazolidinone antimicrobial agent. Clin Ther 23:356\u2013391","journal-title":"Clin Ther"},{"key":"9518_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09273948.2013.874447","volume":"23","author":"R Agrawal","year":"2015","unstructured":"Agrawal R, Addison P, Saihan Z, Pefkianaki M, Pavesio C (2015) Optic neuropathy secondary to linezolid for multidrug-resistant mycobacterial spinal tuberculosis. Ocul Immunol Inflamm 23:90\u201392","journal-title":"Ocul Immunol Inflamm"},{"key":"9518_CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4103\/0301-4738.118451","volume":"62","author":"D Karuppannasamy","year":"2014","unstructured":"Karuppannasamy D, Raghuram A, Sundar D (2014) Linezolid-induced optic neuropathy. Indian J Ophthalmol 62:497\u2013500","journal-title":"Indian J Ophthalmol"},{"key":"9518_CR9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/WNO.0b013e31829b4265","volume":"33","author":"J Han","year":"2013","unstructured":"Han J, Lee K, Rhiu S, Lee JB, Han SH (2013) Linezolid-associated optic neuropathy in a patient with drug-resistant tuberculosis. J Neuroophthalmol 33:316\u2013318","journal-title":"J Neuroophthalmol"},{"key":"9518_CR10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10384-009-0678-3","volume":"53","author":"K Kiuchi","year":"2009","unstructured":"Kiuchi K, Miyashiro M, Kitagawa C, Wada S (2009) Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis. Jpn J Ophthalmol 53:420\u2013424","journal-title":"Jpn J Ophthalmol"},{"key":"9518_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/bjo.2006.102541","volume":"91","author":"M Javaheri","year":"2007","unstructured":"Javaheri M, Khurana RN, O\u2019Hearn TM, Lai MM, Sadun AA (2007) Linezolid-induced optic neuropathy: a mitochondrial disorder? Br J Ophthalmol 91:111\u2013115","journal-title":"Br J Ophthalmol"},{"key":"9518_CR12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajo.2004.11.047","volume":"139","author":"T Saijo","year":"2005","unstructured":"Saijo T, Hayashi K, Yamada H, Wakakura M (2005) Linezolid-induced optic neuropathy. Am J Ophthalmol 139:1114\u20131116","journal-title":"Am J Ophthalmol"},{"key":"9518_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00041327-200503000-00005","volume":"25","author":"SH McKinley","year":"2005","unstructured":"McKinley SH, Foroozan R (2005) Optic neuropathy associated with linezolid treatment. J Neuroophthalmol 25:18\u201321","journal-title":"J Neuroophthalmol"},{"key":"9518_CR14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/379012","volume":"37","author":"E Lee","year":"2003","unstructured":"Lee E, Burger S, Shah J, Melton C, Mullen M, Warren F, Press R (2003) Linezolid-associated toxic optic neuropathy: a report of 2 cases. Clin Infect Dis 37:1389\u20131391","journal-title":"Clin Infect Dis"},{"key":"9518_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-011-9296-8","volume":"124","author":"DC Hood","year":"2012","unstructured":"Hood DC, Bach M, Brigell M, Keating D, Kondo M, Lyons JS, Marmor MF, McCulloch DL, Palmowski-Wolfe AM, International Society For Clinical Electrophysiology of V (2012) ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124:1\u201313","journal-title":"Doc Ophthalmol"},{"key":"9518_CR16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/WNO.0b013e31818e3ece","volume":"28","author":"Y Liu","year":"2008","unstructured":"Liu Y, Dinkin MJ, Loewenstein JI, Rizzo JF 3rd, Cestari DM (2008) Multifocal electroretinographic abnormalities in ethambutol-induced visual loss. J Neuroophthalmol 28:278\u2013282","journal-title":"J Neuroophthalmol"},{"key":"9518_CR17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/bjo.2004.058099","volume":"89","author":"TY Lai","year":"2005","unstructured":"Lai TY, Chan WM, Lam DS, Lim E (2005) Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy. Br J Ophthalmol 89:774\u2013775","journal-title":"Br J Ophthalmol"},{"key":"9518_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10633-012-9329-y","volume":"125","author":"K Kuniyoshi","year":"2012","unstructured":"Kuniyoshi K, Sakuramoto H, Nakao A, Takada S, Shimomura Y (2012) A case of bilateral, acquired, and acute dysfunction of short-wavelength-sensitive cone systems. Doc Ophthalmol 125:75\u201380","journal-title":"Doc Ophthalmol"},{"key":"9518_CR19","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1111\/j.1755-3768.2010.01958.x","volume":"89","author":"YG Kim","year":"2011","unstructured":"Kim YG, Baek SH, Moon SW, Lee HK, Kim US (2011) Analysis of spectral domain optical coherence tomography findings in occult macular dystrophy. Acta Ophthalmol 89:e52\u2013e56","journal-title":"Acta Ophthalmol"},{"key":"9518_CR20","first-page":"266","volume":"10","author":"MI Mantyjarvi","year":"1990","unstructured":"Mantyjarvi MI (1990) Color vision defect as first symptom of progressive cone-rod dystrophy. J Clin Neuroophthalmol 10:266\u2013270","journal-title":"J Clin Neuroophthalmol"},{"key":"9518_CR21","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1167\/iovs.09-4169","volume":"51","author":"SJ Park","year":"2010","unstructured":"Park SJ, Woo SJ, Park KH, Hwang JM, Chung H (2010) Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. Investig Ophthalmol Vis Sci 51:3673\u20133679","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"9518_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1022591317907","volume":"106","author":"MF Marmor","year":"2003","unstructured":"Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y, International Society for Clinical Electrophysiology of V (2003) Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106:105\u2013115","journal-title":"Doc Ophthalmol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-015-9518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-015-9518-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-015-9518-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:00:39Z","timestamp":1559232039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-015-9518-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9518"],"URL":"https:\/\/doi.org\/10.1007\/s10633-015-9518-6","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]}}}